Profile
ACIU VRTX REGN SGEN ALNY ARGX
Company Name AC Immune SA Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $186.01M $116.96B $54.11B $43.15B $38.15B $33.66B
Employees 0.13K 6.10K 15.16K 3.26K 2.23K 1.60K
CEO Dr. Andrea Pfeifer Ph.D. Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Dr. Yvonne L. Greenstreet M.B.A., M.D. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
ACIU VRTX REGN SGEN ALNY ARGX
Quant Rating Score 2 2 4 3 1 1
Quant Rating Sell Sell Buy Neutral Strong Sell Strong Sell
Trading
ACIU VRTX REGN SGEN ALNY ARGX
Last Close $2.07 $445.82 $520.29 $228.74 $321.94 $560.53
High 52 $4.2 $516.74 $1201.76 $228.74 $325 $671.75
Low 52 $1.48 $396.64 $482.92 $228.74 $224.58 $430.04
Price vs. 52 Week High -50.71 % -13.72 % -56.71 % 0 % -0.94 % -16.56 %
Price vs. 52 Week Low 39.86 % 12.4 % 7.74 % 0 % 43.35 % 30.34 %
Total Return
ACIU VRTX REGN SGEN ALNY ARGX
1 Month Return 22.49 % 2.25 % -11.57 % 0 % 11.03 % -4.61 %
3 Month Return 4.02 % -10.89 % -18.72 % 0 % 19.59 % -3.96 %
6 Month Return -23.48 % 8.56 % -27.4 % 0 % 32.76 % -11.31 %
9 Month Return -44.05 % -3.74 % -49.97 % 0 % 17.25 % 6.85 %
YTD Return -23.33 % 10.71 % -26.96 % 0 % 36.82 % -8.86 %
1 Year Return -47.86 % -5.95 % -51.34 % 0 % 31.31 % 25.71 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACIU VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.35 % - - -
Dividend Paid and Capex Coverage Ration (TTM) 66.77 % -3.53 % 3.85 % -5.87 % -1.49 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Profitability
ACIU VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM 39.44 % 86.03 % 84.94 % 79.1 % 86.01 % 46.33 %
Return on Assets TTM -24.67 % -4.32 % 11.98 % -16.61 % -6.4 % 13.45 %
Return on Equity TTM -45.22 % -6.25 % 14.77 % -20.8 % -509.33 % 16.83 %
Return on Capital Employed TTM -46.21 % -3.89 % 11.35 % -21.46 % -3.68 % -0.5 %
Net Income Per EBT TTM 100.01 % 329.41 % 90.27 % 101.33 % 75.89 % 25990.14 %
EBT Per Ebit TTM 100.77 % 40.44 % 129.3 % 98.26 % 308.03 % -11.64 %
EBIT Per Revenue TTM -182.62 % -6.69 % 27.37 % -31.24 % -4.91 % -1.24 %
Cash Flow To Debt Ratio TTM 888.93 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Receivables Turnover TTM 9.71 6.15 2.53 3.91 5.62 2.36
Payables Turnover TTM 7.17 3.49 3.01 1.97 3.37 2.39
Inventory Turnover TTM - 1.14 0.66 0.96 5.01 2.93
Fixed Asset Turnover TTM 356.1 % 421.34 % 300.07 % 665.41 % 337.41 % 5106.8 %
Asset Turnover TTM 13.41 % 48.51 % 37.52 % 53.41 % 55.72 % 35.83 %
Operating Cash Flow Per Share TTM 0.46 -3.82 37.05 -2.46 -0.35 -1.07
Free Cash Flow Per Share TTM 0.45 -4.9 28.3 -2.88 -0.58 -1.09
Cash Per Share TTM 145.02 % 2413.86 % 7825.12 % 939.52 % 2024.29 % 4688.94 %
Operating Cash Flow Sales Ratio TTM 162.56 % -8.83 % 28.06 % -23.12 % -1.92 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 98.5 % 128.33 % 76.4 % 117.04 % 167.11 % 102.26 %
Cash Flow Coverage Ratios TTM 888.93 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Price To Free Cash Flows Ratio TTM 3.36 -92.97 17.92 -81.26 -506.05 -433.65
Price To Operating Cash Flows Ratio TTM 3.35 -119.36 13.76 -93.1 -841.05 -515.25
Price Cash Flow Ratio TTM 3.35 -119.36 13.76 -93.1 -841.05 -515.25
Income Statement (TTM)
ACIU VRTX REGN SGEN ALNY ARGX
Revenue $0.03B $11.02B $14.2B $1.96B $2.25B $2.19B
Gross Profit $0.03B $9.49B $12.23B $1.55B $1.92B $1.96B
Gross Profit Ratio 100% 86.11% 86.13% 79.1% 85.62% 89.62%
EBITDA $-0.05B $0.49B $5.32B $-0.62B $-0.18B $0.11B
Net Income $-0.05B $-0.54B $4.41B $-0.61B $-0.28B $0.83B
EPS Diluted -0.51 -2.08 38.34 -3.3 -2.16 12.78
Balance Sheet (MRQ)
ACIU VRTX REGN SGEN ALNY ARGX
Long Term Debt $0B $1.66B $1.98B $0.04B $0B $0.03B
Total Liabilities $0.12B $6.12B $8.41B $0.87B $4.17B $0.7B
Total Equity $0.11B $16.41B $29.35B $2.8B $0.07B $5.5B
Total Investments $0.13B $6.65B $15.42B $1.42B $1.73B $1.93B
Total Debt $0.01B $1.75B $2.7B $0.04B $1.3B $0.04B
Total Assets $0.23B $22.53B $37.76B $3.67B $4.3B $6.2B
Cash Flow Statement (TTM)
ACIU VRTX REGN SGEN ALNY ARGX
Net Income $-0.05B $-0.54B $4.41B $-0.61B $-0.28B $-0.02B
Inventory $0B $-0.52B $-0.62B $-0.23B $0.01B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $0.07B $-0.49B $4.42B $-0.45B $-0.01B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.08B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 40.67
AARD Aardvark Therapeutics, Inc. Common Stock 13.95
ABCL AbCellera Biologics Inc. 3.7376
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.91
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.225
ABPWW 0.0292
ABSI Absci Corporation 2.71
ABUS Arbutus Biopharma Corporation 3.195
ABVC ABVC BioPharma, Inc. 2.175
ABVX Abivax SA American Depositary Shares 7.15
ACAD ACADIA Pharmaceuticals Inc. 22.22
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.6714
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 3.49
ACLX Arcellx, Inc. 64.835
ETFs With Exposure to ACIU
Ticker ETF Name Weight Percentage Price
IBB iShares Biotechnology ETF 0.01363 127.01
GWX SPDR S&P International Small Cap ETF 0.02 36.855
BIB ProShares Ultra Nasdaq Biotechnology 0.0152771 45.87
SBIO ALPS Medical Breakthroughs ETF 0.002 30.64
BMED BlackRock Future Health ETF 0.0106 24.75
IBBQ Invesco Nasdaq Biotechnology ETF 0.021 21.18
DFAT Dimensional U.S. Targeted Value ETF 0.00030086 53.885
DFAS Dimensional U.S. Small Cap ETF 0.00000797 63.57
DFAC Dimensional U.S. Core Equity 2 ETF 0.00007942 35.55
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.02102 5.268
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.02102 6.17
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.02102 6.144
QQQS Invesco NASDAQ Future Gen 200 ETF 0.406 26.885
DFSU Dimensional US Sustainability Core 1 ETF 0.00026094 38.885
BTEK.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.02102 4.494
DXUV Dimensional ETF Trust 0.00002414 53.82
Unlock